List of companies in Celgene's investment portfolio
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
Exscientia is an Oxford-based biotechnology company using artificial intelligence to automate drug discovery. | ||||||
Celgene discovers, develops and commercializes innovative therapies to treat cancer and immune-inflammatory-related diseases. | ||||||
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived. | ||||||
A biopharmaceutical and gene editing company founded in 2013. CRISPR Therapeutics AG is based in Zug, Switzerland and CRISPR Therapeutics, Inc. is the U.S. subsidiary with R&D operations in Cambridge, Massachusetts and business offices in London, U.K. | ||||||
Agios Pharmaceuticals is a public American pharmaceutical company | ||||||
A biopharmaceutical company focused on the discovery, development and commercialization of therapeutics for the treatment of serious and rare diseases | ||||||
Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company that is pioneering the development of transformative therapies for patients who are with serious diseases that include hematologic cancers, solid tumors and autoimmune diseases. | ||||||
A biopharmaceutiical company discovering, developing and manufacturing therapeutics for the treatment of canccer | ||||||
Arrakis is developing RNA-targeted small molecule (rSM) therapies to millions of patients. | ||||||
NantHealth is a Culver City, California-based company providing an evidence-based platform for healthcare diagnostics. | ||||||
IDEAYA Biosciences is an oncology-focused biotechnology company committed to the discovery of breakthrough synthetic lethality | ||||||
Silverback Therapeutics is a Seattle-based biopharmaceutical company developing ImmunoTAC therapies targeting previously inaccessible disease pathways. | ||||||
Antengene is a clinical-stage Asia-Pacific biopharmaceutical company focused on innovative oncology medicines. | ||||||
Epizyme is a biopharmaceutical company focused on the discovery and development of epigenetic medicines to treat cancer and other disease | ||||||
Cyteir Therapeutics is a rapid destruction of cancer cells founded in 2012 by Tim Romberger. | ||||||
Repare Therapeutics is a synthetic Lethal Therapeutics founded in 2016 by Daniel Durocher, Agnel Sfeir and Frank Sicheri. | ||||||
Evelo Biosciences is a Cambridge, Massachusetts-based biotechnology company focusing on inflammatory conditions. | ||||||
Biond Biologics is an Israel-based immunotherapy company developing treatments for cancer and autoimmune diseases. | ||||||
Vividion Therapeutics is a proprietary Screening founded in 2017. | ||||||
Agenovir Corporation was a biotechnology company founded in 2014 which was acquired by Vir Biotechnology in 2018. | ||||||
Cleave Therapeutics is a San Francisco-based biotechnology company focused on protein homeostasis and stress pathways in cancer and neurodegeneration. | ||||||
Tengion is a biotechnology company developing neo-organs and neo-tissue founded in 2002. | ||||||
Juno is a New York City-based company founded in 2015 by Talmon Marco. | ||||||
Armo Bio Sciences is a Redwood City, California-based company. | ||||||
Anokion is an immune-tolerated therapeutic proteins founded by Melody Swartz. |
